Mike Dybbs

Dr. Dybbs has over 15 years of investment and consulting experience in the life science sector. Dr. Dybbs is currently a Partner at Samsara BioCapital. Prior to joining Samsara, Dr. Dybbs was a Partner at New Leaf Venture Partners, which he joined in 2009. Before New Leaf, Dr. Dybbs was a Principal at The Boston Consulting Group, where he was a core member of their Health Care practice. Dr. Dybbs currently serves as a director of Levo Therapeutics, Sutro BioPharma, and IONpath. Previously, he served on the boards of Versartis, Dimension Therapeutics, Principia, and Advanced Cell Diagnostics.

Dr. Dybbs earned a Ph.D. in Molecular and Cellular Biology and Genetics from the University of California, Berkeley, where he was awarded a Howard Hughes Medical Institute fellowship and received an A.B. in Biomedical Sciences from Harvard University. His research had been published in peer-reviewed journals, including Science, Nature, and Neuron.